The Community Oncology Alliance appoints new officers

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

THE COMMUNITY ONCOLOGY ALLIANCE appointed new officers. Bruce Gould, of Northwest Georgia Oncology Centers in Marietta, Ga., was named president of COA.

Jeff Vacirca, of North Shore Hematology Oncology Associates in East Setauket, N.Y., was named vice-president; Michael Diaz, of Florida Cancer Specialists and Research Institute in Tampa, Fla., was named secretary; and Ricky Newton, of Cancer Specialists of Tidewater in Chesapeake, Va, was named treasurer.

The COA’s immediate past president is Mark Thompson, of The Zangmeister Center in Columbus, Ohio, who will continue to serve as chairman of the COA Payment Reform Task Force and legislative liaison on congressional matters. Past President David Eagle, of Lake Norman Hematology Oncology in Charlotte, N.C., will assume the position of chairman of the Oncology Medical Home Steering Committee.

YOU MAY BE INTERESTED IN

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.
When it comes to fighting cancer today, collaboration is key. At a time when funding is uncertain, yet innovative breakthroughs are accelerating every day, it’s more important than ever for oncologists, scientists, academic researchers, and community physicians, to come together to share knowledge and gain insights about the forefront of cancer research.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login